Use of nebulized inhaled corticosteroids among older adult patients: An assessment of outcomes

Annals of Allergy, Asthma and Immunology

Volumn 96, Issue 5, 2006, Pages 736-743

  Marcus, Philip ^a   Oppenheimer, Edward A ^b   Patel, Pankaj A ^c   Katz, Laura M ^d   Doyle, John J ^d  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ASTRAZENECA   (United Kingdom)

^d Analytica International   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC SINUSITIS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DATA BASE; EMERGENCY WARD; EMPHYSEMA; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL NEBULIZER; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 33646723745     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61074-5     Document Type: Article

References (43)

1. Centers for Disease Control and Prevention. Asthma prevalence and control characteristics by race/ethnicity - United States, 2002. MMWR Morb Mortal Wkly. 2004;53:145-168.
2. Kim YK, Kim SH, Tak YJ, et al. High prevalence of current asthma and active smoking effect among the elderly. Clin Exp Allergy. 2002;32:1706-1712.
3. Ishioka S, Terada M, Haruta Y, Hiyama K, Hozawa S, Yamakido M. Multiple logistic regression analysis of risk factors for the development of steroid-dependent asthma in the elderly: a comparison with younger asthmatics. Respiration. 2001;68:35-40.
4. National Institutes of Health. National Heart, Lung, and Blood Institute. Data Fact Sheet: Asthma Statistics. Washington, DC: US Department of Health and Human Services; 1999:1-4.
5. Centers for Disease Control and Prevention, National Center for Health Statistics. Asthma Prevalence by Age, Gender, Race/Ethnicity, and Geographic Region/Division, 1999-2003. Available at: 2003:http://209.217.72.34/asthma/ TableViewer/tableView.aspx?ReportId=16. Accessed May 31, 2005.
6. Moorman JE, Mannino DM. Increasing U.S. asthma mortality rates: who is really dying? J Asthma. 2001;38:65-71.
7. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood). 2001;20:233-241.
8. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis, I: assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8.
9. Cisternas MG, Blanc PD, Yen IH, et al. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003;111:1212-1218.
10. Plaza V, Serra-Batlles J, Ferrer M, Morejon E. Quality of life and economic features in elderly asthmatics. Respiration. 2000;67:65-70.
11. Centers for Disease Control and Prevention, National Center for Health Statistics. Asthma Mortality by Age, Gender, Race/Ethnicity and Region/State, 1998-2002. Available at: http://209.217.72.34/asthma/TableViewer/tableView.aspx? ReportId= 12 2002. Accessed June 23, 2005.
12. Dow L, Fowler L, Phelps L, et al. Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK. Thorax. 2001;56:472-476.
13. Banerjee DK, Lee GS, Malik SK, Daly S. Underdiagnosis of asthma in the elderly. Br J Dis Chest. 1987;81:23-29.
14. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD; Cardiovascular Health Study Research Group. Underdiagnosis and undertreatment of asthma in the elderly. Chest. 1999;116:603-613.
15. Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002: National Asthma Education and Prevention Program Expert Panel Report. Bethesda, MD: National Heart, Lung, and Blood Institute; 2002.
16. Balzano G, Battiloro R, Biraghi M, et al. Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med. 2000;13:25-33.
17. Newnham DM. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Drug Saf. 2001;24:1065-1080.
18. Brocklebank D, Ram F, Wright J, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:1-149.
19. Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156:984-988.
20. Allen SC, Jain M, Ragab S, Malik N. Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing. 2003;32:299-302.
21. Renwick DS, Connolly MJ. Improving outcomes in elderly patients with asthma. Drugs Aging. 1999;14:1-9.
22. Rubin BK. What does it mean when a patient says, "my asthma medication is not working?" Chest. 2004;126:972-981.
23. Pedersen S. Inhalers and nebulizers: which to choose and why. Respir Med. 1996;90:69-77.
24. O'Donohue WJ Jr. Guidelines for the use of nebulizers in the home and at domiciliary sites: report of a consensus conference: National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group. Chest. 1996;109:814-820.
25. Hvizdos KM, Jarvis B. Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders. Drugs. 2000;60:1141-1178.
26. Connolly KC, Peake PD, Halpin DMG, et al. Challenging current asthma treatment guidelines: improved control of asthma symptoms with nebulized budesonide in patients with severe asthma receiving continuous oral steroids. Dis Manage Health Outcomes. 2000;7:217-225.
27. Higenbottam TW, Britton J, Lawrence D. Comparison of nebulized budesonide and prednisolone in severe asthma exacerbations in adults. Biol Drugs. 2000;2000:247-254.
28. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1988.
29. Redbook. Redbook (TM) for Windows, version 5.0. Greenwood Village, CO: Micromedex Inc; 2003.
30. Millennium Edition, Health Care Procedure Coding System, National Level II, Medicare Codes. Los Angeles, CA: Practice Management Information Corporation; 2003.
31. Vollmer WM, O'Hollaren M, Ettinger KM, et al. Specialty differences in the management of asthma: a cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med. 1997;157:1201-1208.
32. Vollmer WM, Swain MC. Role of the specialist in the treatment of asthma. Curr Opin Allergy Clin Immunol. 2002;2:189-194.
33. Diette GB, Skinner EA, Nguyen TT, Markson L, Clark BD, Wu AW. Comparison of quality of care by specialist and generalist physicians as usual source of asthma care for children. Pediatrics. 2001;108:432-437.
34. Storms B, Olden L, Nathan R, Bodman S. Effect of allergy specialist care on the quality of life in patients with asthma. Ann Allergy Asthma Immunol. 1995;75:491-494.
35. Li JT, Sheeler RD, Offord KP, Patel AM, Dupras DM. Consultation for asthma: results of a generalist survey. Ann Allergy Asthma Immunol. 1999;83:203-206.
36. National Institutes of Health. Considerations for Diagnosing and Managing Asthma in the Elderly: NAEPP Working Group Report. Bethesda, MD: National Heart, Lung, and Blood Institute; 1996.
37. Bellia V, Battaglia S, Catalano F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest. 2003;123:1066-1072.
38. Barger LW, Vollmer WM, Felt RW, Buist AS. Further investigation into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy. 1988;60:31-39.
39. Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med. 2002;17:717-720.
40. Allen-Ramey FC, Duong PT, Goodman DC, et al. Treatment effectiveness of inhaled corticosteroids and leukotriene modifiers for patients with asthma: an analysis from managed care data. Allergy Asthma Proc. 2003;24:43-51.
41. Labrecque M, Laurier C, Champagne F, Kennedy W, Pare M, Cartier A. Effect of age on the conformity rate to short-acting beta-agonist use criteria in asthma. J Asthma. 2003;40:829-835.
42. Lynd LD, Guh DP, Pare PD, Anis AH. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest. 2002;122:1973-1981.
43. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM. Asthma variability in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol. 2003;112:1088-1094.